Dermoph

Dermoph.com sells a tightly curated line of dermocosmetic treatments: fragrance-free cleansers, barrier creams, lipid-replenishing balms, and SPF50 mineral sunscreens. All SKUs sit in the mid-range bracket (€18-€38 for 50-200 ml) and are available only through the brand’s own e-commerce site, which ships across the EU from a Lyon warehouse. The formulas are built around a patented 3:1:1 ceramide-cholesterol-free fatty acid ratio developed with Toulouse dermatology professors; every product is manufactured in small 300-litre batches, sealed under nitrogen, and lot-tracked with a public COA. The “Cica-Ph” duo—tube balm and pocket stick—has become a cult repeat-purchase item, accounting for 42 % of 2023 revenue. Core buyers are 25-45-year-old urban professionals who self-identify as having reactive or prescription-treated skin and who actively avoid fragrance, essential oils, and denatured alcohol. They value traceability, short INCI lists, and medical-staging data posted in plain language; the brand’s Instagram Q&A with resident pharmacists every Thursday reinforces that trust. Dermoph competes with pharmacy-positioned dermocosmetic houses that rely on wide retail footprint and frequent promo cycles; it counters by staying digital-direct, limiting SKU count to nine, and publishing stability-test graphs for each batch. The resulting gross margin is reinvested into higher raw-material percentages rather than retailer margins, letting the formulas match premium ceramide benchmarks at a 25-30 % lower price per millilitre.